King’s Health Partners hosted Professor A Thomas McLellan, Deputy Director and Chief Scientist, White House Office of National Drug Control Policy (ONDCP) at the Institute of Psychiatry (IoP), King’s College London on Monday 8 March.
Latest News
Depression: antidepressants beneficial in physically ill patients
Antidepressants are effective against depression in patients suffering from physical illnesses, according to a new systematic review by Cochrane researchers at King’s Health Partners Academic Health Sciences Centre in the UK. The researchers found the drugs were more effective than placebos at treating depression in these patients.
Researchers call for more studies into mental health of health professionals
Researchers from the Institute of Psychiatry (IoP), King’s College London, who contributed to the government’s Health for Health Professionals report, have identified an urgent need for more research on mental disorders amongst healthcare professionals.
King’s Health Partners brand awarded Gold for best public sector rebrand in the Transform Awards 2010
Design agency Further has won the top award in the public sector branding section of the Transform Awards, for the naming and development of the King’s Health Partners brand.
Translational Research and Patient Safety in Europe
King’s College London, part of King’s Health Partners Academic Health Sciences Centre, will lead a consortium of 15 European Universities and two private partners to develop methods, standards and systems for the integration of healthcare computer systems for clinical care and research.




